| Prostate Cancer Therapy Area Pipeline Report | | | | on partnering activity plus clinical trial intelligence. |
| contains detailed information on the prostate | | | | Each Therapy Area Pipeline Report also provides |
| cancer drug pipeline. This report provides insight | | | | detail on the top 20 companies with products in |
| into the pipeline status of prostate cancer drugs | | | | the early stage of development and the top 20 |
| by company and by stage as well as a summary | | | | companies with products in the late stage of |
| of the latest news and developments in this area. | | | | development. Finally, each report also provides a |
| Scope of the report: | | | | comparison with other major indications in the |
| Each Life Science Analytics' Therapy Area Pipeline | | | | disease hub based on Marketed Products vs. |
| Report provides the user with real detail on drug | | | | Pipeline Products. |
| pipelines, by company and by stage, for each | | | | Key benefits |
| specific therapy area. The latest news, by | | | | • Understand a company's strategic position by |
| company, also ensures that each report is fresh | | | | accessing detailed independent intelligence on its |
| and up-to-date. | | | | product pipeline for specific therapy areas. |
| In addition to new developments and disease | | | | • Keep track of your competitors and |
| specific pipeline projects, each report also contains | | | | partners by better understanding their product |
| extensive information in tabular format on a | | | | pipeline. |
| company's full product pipeline and products by | | | | • Monitor a company's research effectiveness |
| phase of development with regard to the therapy | | | | by determining pipeline depth and number of |
| area. | | | | products in development by clinical phase for |
| Full pipeline details, by stage, are provided and | | | | specific disease areas. |
| include detailed product descriptions, information | | | | • Maintain a critical competitive advantage. |